Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C, Naranjo ME, Ramírez R, Serrano V, Fariñas H, Barrantes R, LLerena A; CEIBA Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Céspedes-Garro C, et al. Among authors: llerena a. Drug Metab Pers Ther. 2015 Mar;30(1):19-31. doi: 10.1515/dmdi-2014-0025. Drug Metab Pers Ther. 2015. PMID: 25490028 Review.
Pharmacogenetics of clinical response to risperidone.
Llerena A, Berecz R, Peñas-Lledó E, Süveges A, Fariñas H. Llerena A, et al. Pharmacogenomics. 2013 Jan;14(2):177-94. doi: 10.2217/pgs.12.201. Pharmacogenomics. 2013. PMID: 23327578 Review.
Impact of cytochrome P450 genes on suicide attempt and risk.
Peñas-Lledó EM, Naranjo ME, Llerena A. Peñas-Lledó EM, et al. Among authors: llerena a. Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):703-4. doi: 10.1007/s00406-013-0402-7. Epub 2013 Mar 16. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 23504002 No abstract available.
MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers.
González-Vacarezza N, Dorado P, Peñas-Lledó EM, Fariñas H, Estévez-Carrizo FE, Llerena A. González-Vacarezza N, et al. Among authors: llerena a. Drug Metabol Drug Interact. 2013;28(3):163-6. doi: 10.1515/dmdi-2013-0008. Drug Metabol Drug Interact. 2013. PMID: 23740681 Clinical Trial.
Present status and perspective of pharmacogenetics in Mexico.
Cuautle-Rodríguez P, Llerena A, Molina-Guarneros J. Cuautle-Rodríguez P, et al. Among authors: llerena a. Drug Metabol Drug Interact. 2014;29(1):37-45. doi: 10.1515/dmdi-2013-0019. Drug Metabol Drug Interact. 2014. PMID: 24129103 Review.
Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
Céspedes-Garro C, Jiménez-Arce G, Naranjo ME, Barrantes R, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF. Céspedes-Garro C, et al. Among authors: llerena a. Rev Biol Trop. 2014 Dec;62(4):1659-71. Rev Biol Trop. 2014. PMID: 25720195
Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014).
Sosa-Macias M, Moya GE, LLerena A, Ramírez R, Terán E, Peñas-LLedó EM, Tarazona-Santos E, Galaviz-Hernández C, Céspedes-Garro C, Acosta H. Sosa-Macias M, et al. Among authors: llerena a. Pharmacogenomics. 2015;16(7):673-6. doi: 10.2217/pgs.15.32. Epub 2015 May 1. Pharmacogenomics. 2015. PMID: 25929854 Free article.
Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.
Céspedes-Garro C, Fricke-Galindo I, Naranjo ME, Rodrigues-Soares F, Fariñas H, de Andrés F, López-López M, Peñas-Lledó EM, LLerena A. Céspedes-Garro C, et al. Among authors: llerena a. Expert Opin Drug Metab Toxicol. 2015;11(12):1893-905. doi: 10.1517/17425255.2015.1111871. Epub 2015 Nov 23. Expert Opin Drug Metab Toxicol. 2015. PMID: 26595139 Review.
249 results